"
Team:UCL
From 2013.igem.org
| Line 196: | Line 196: | ||
<p class="abstract_text" style="color:#404040;"> | <p class="abstract_text" style="color:#404040;"> | ||
| - | + | This year, the UCL iGEM team is taking a radical new step with synthetic biology. We intend to explore the potential application genetic engineering techniques on the brain, because it is the site of some of the most subtle, and many of the most devastating medical conditions. Alzheimer’s Disease is a neurodegenerative disease characterised by the loss of recent memory and intellectual functions. We have devised a genetic circuit for transfection into microglia, a novel chassis in which standard assembly has never been used, to boost their ability to break down senile plaques, which are associated with Alzheimer’s disease, as well as to support and protect endangered neurons from microglia-mediated neuroinflammation. | |
<br><br> | <br><br> | ||
</p> | </p> | ||
Latest revision as of 03:56, 5 October 2013
IGEM: INTELLIGENTLY GENETICALLY ENGINEERED MICROGLIA
Synthetic Biology Fights Alzheimer's Disease
This year, the UCL iGEM team is taking a radical new step with synthetic biology. We intend to explore the potential application genetic engineering techniques on the brain, because it is the site of some of the most subtle, and many of the most devastating medical conditions. Alzheimer’s Disease is a neurodegenerative disease characterised by the loss of recent memory and intellectual functions. We have devised a genetic circuit for transfection into microglia, a novel chassis in which standard assembly has never been used, to boost their ability to break down senile plaques, which are associated with Alzheimer’s disease, as well as to support and protect endangered neurons from microglia-mediated neuroinflammation.
